Hung-Yin Yeh, NP
Nurse Practitioner · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
- Since medical school
- 8 years
- Graduated 2018
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Hung-Yin Yeh’s office at (650) 691-6174 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$34,768
Medicare paid this office $34,768 for 134 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 129 | $27,733 | $97 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 56 | $3,309 | $26 |
| Long return visit (40+ min) | 12 | $1,919 | $148 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 56 | $1,187 | $13 |
Who their Medicare patients are
134 Original Medicare patients in 2024. Average age 78 · Women 48% · Also on Medicaid 16% · Health risk score 1.81. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 75% · Chronic kidney disease 68% · Coronary heart disease 38% · Heart failure 23% · Atrial fibrillation 21% · Depression 16% · Cancer 12% · Stroke 10% · Dementia 9%.
The office billed $145,849, Medicare allowed $47,114 and paid $34,768; for 527 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 134 | 527 | 78 | 1.81 | $145,849 | $34,768 |
| 2023 | 144 | 456 | 77 | 1.52 | $145,033 | $35,712 |
| 2022 | 128 | 382 | 74 | 1.84 | $107,867 | $29,002 |
| 2021 | 22 | 89 | 78 | 1.92 | $12,643 | $4,024 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 135 | $28,383 | $96 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 58 | $3,215 | $25 |
| New patient visit (60+ min) | 13 | $2,161 | $166 |
| Long return visit (40+ min) | 12 | $1,722 | $132 |
2022: 4 services
| Return visit (30+ min) | 110 | $18,431 | $98 |
| Long return visit (40+ min) | 26 | $4,318 | $139 |
| New patient visit (60+ min) | 16 | $2,816 | $176 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 42 | $2,200 | $26 |
2021: 1 service
| Return visit (30+ min) | 12 | $1,285 | $107 |
Drugs they prescribed that Part D paid
$842,441
Pharmacies billed $842,441 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,440) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
631 generic and 713 brand-name prescriptions · $842,441 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 143 | $246,702 | $1,725 |
| Mounjaro | 73 | $108,126 | $1,481 |
| Jardiance | 79 | $106,829 | $1,352 |
| Trulicity | 39 | $73,160 | $1,876 |
| Synjardy Xr | 20 | $33,366 | $1,668 |
See all 28 drugs
| Ozempic | 143 | $246,702 | $1,725 |
| Mounjaro | 73 | $108,126 | $1,481 |
| Jardiance | 79 | $106,829 | $1,352 |
| Trulicity | 39 | $73,160 | $1,876 |
| Synjardy Xr | 20 | $33,366 | $1,668 |
| Januvia | 22 | $32,814 | $1,492 |
| Tradjenta | 19 | $15,507 | $816 |
| Lantus Solostar | 78 | $13,124 | $168 |
| Tresiba Flextouch U-100 | 14 | $11,260 | $804 |
| Novolog Mix 70-30 Flexpen | 18 | $11,127 | $618 |
| Humalog Kwikpen U-100 | 37 | $10,617 | $287 |
| Testosterone | 44 | $8,128 | $185 |
| Basaglar Kwikpen U-100 | 21 | $6,346 | $302 |
| Nano 2nd Gen Pen Needle | 60 | $5,359 | $89 |
| Humalog | 12 | $3,279 | $273 |
| Novolog Flexpen | 11 | $2,706 | $246 |
| Ultra-Fine Mini Pen Needle | 13 | $1,336 | $103 |
| Testosterone Cypionate | 38 | $1,054 | $28 |
| Atorvastatin | 78 | $937 | $12 |
| Metformin | 70 | $894 | $13 |
| Glipizide Er | 38 | $871 | $23 |
| Metformin Hcl Er | 52 | $795 | $15 |
| Glipizide | 70 | $786 | $11 |
| Levothyroxine | 41 | $544 | $13 |
| Glimepiride | 54 | $537 | $10 |
| Losartan | 20 | $261 | $13 |
| Lisinopril | 19 | $187 | $10 |
| Pioglitazone | 14 | $76 | $5 |
Year by year
| 2024 | 1,440 | 213 | 0% (0) | 50% | $842,441 |
| 2023 | 986 | 201 | 0% (0) | 52% | $797,943 |
| 2022 | 590 | 183 | 0% (0) | 45% | $354,339 |
| 2021 | 1,215 | 200 | None | 41% | $491,896 |
| 2020 | 1,387 | 188 | None | 40% | $518,903 |
| 2019 | 781 | 150 | 0% (0) | 35% | $252,676 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Ozempic | 76 | $169,474 | $2,230 |
| Trulicity | 72 | $115,549 | $1,605 |
| Jardiance | 53 | $87,645 | $1,654 |
| Lantus Solostar | 60 | $52,706 | $878 |
| Mounjaro | 35 | $48,265 | $1,379 |
| Humalog Kwikpen U-100 | 18 | $29,387 | $1,633 |
| Synjardy Xr | 16 | $25,954 | $1,622 |
| Januvia | 14 | $22,996 | $1,643 |
| Tradjenta | 17 | $17,532 | $1,031 |
| Testosterone | 42 | $12,653 | $301 |
| Novolog Flexpen | 12 | $9,519 | $793 |
| Nano 2nd Gen Pen Needle | 42 | $3,544 | $84 |
| Glipizide Er | 30 | $1,662 | $55 |
| Testosterone Cypionate | 31 | $1,193 | $38 |
| Glipizide | 60 | $999 | $17 |
| Levothyroxine | 41 | $843 | $21 |
| Insulin | 13 | $683 | $53 |
| Glimepiride | 39 | $579 | $15 |
| Metformin Hcl Er | 29 | $473 | $16 |
| Atorvastatin | 28 | $371 | $13 |
| Metformin | 28 | $337 | $12 |
| Losartan | 12 | $163 | $14 |
| Lisinopril | 13 | $45 | $3 |
2022: 18 drugs
| Ozempic | 47 | $93,593 | $1,991 |
| Trulicity | 23 | $43,639 | $1,897 |
| Jardiance | 32 | $42,010 | $1,313 |
| Lantus Solostar | 36 | $26,246 | $729 |
| Januvia | 17 | $17,047 | $1,003 |
| Farxiga | 14 | $15,040 | $1,074 |
| Tradjenta | 11 | $9,459 | $860 |
| Tresiba Flextouch U-100 | 13 | $8,294 | $638 |
| Testosterone | 23 | $6,736 | $293 |
| Nano 2nd Gen Pen Needle | 21 | $1,533 | $73 |
| Testosterone Cypionate | 21 | $1,190 | $57 |
| Rosuvastatin | 13 | $1,181 | $91 |
| Levothyroxine | 25 | $485 | $19 |
| Glimepiride | 31 | $371 | $12 |
| Metformin Hcl Er | 24 | $285 | $12 |
| Atorvastatin | 16 | $177 | $11 |
| Glipizide | 25 | $173 | $7 |
| Metformin | 16 | $170 | $11 |
2021: 32 drugs
| Ozempic | 70 | $103,313 | $1,476 |
| Trulicity | 73 | $73,114 | $1,002 |
| Jardiance | 45 | $38,532 | $856 |
| Humalog Kwikpen U-200 | 12 | $25,132 | $2,094 |
| Invokana | 22 | $20,320 | $924 |
| Farxiga | 34 | $19,974 | $587 |
| Tradjenta | 14 | $16,055 | $1,147 |
| Xigduo Xr | 13 | $15,285 | $1,176 |
| Janumet Xr | 11 | $12,961 | $1,178 |
| Lyumjev Kwikpen U-100 | 13 | $11,847 | $911 |
| Januvia | 21 | $10,072 | $480 |
| Glyxambi | 15 | $9,493 | $633 |
| Vascepa | 11 | $6,353 | $578 |
| Tresiba Flextouch U-100 | 12 | $5,246 | $437 |
| Rosuvastatin | 52 | $2,582 | $50 |
| Repaglinide | 31 | $1,938 | $63 |
| Synthroid | 17 | $1,286 | $76 |
| Atorvastatin | 73 | $1,052 | $14 |
| Valsartan | 22 | $1,010 | $46 |
| Pioglitazone | 32 | $901 | $28 |
| Ezetimibe | 15 | $875 | $58 |
| Irbesartan | 21 | $829 | $39 |
| Metformin Hcl Er | 64 | $632 | $10 |
| Glimepiride | 48 | $522 | $11 |
| Losartan | 23 | $516 | $22 |
| Levothyroxine | 26 | $455 | $18 |
| Lisinopril | 36 | $380 | $11 |
| Amlodipine Besylate | 30 | $315 | $10 |
| Glipizide | 24 | $298 | $12 |
| Metformin | 22 | $291 | $13 |
| Allopurinol | 15 | $217 | $14 |
| Hydrochlorothiazide | 12 | $82 | $7 |
2020: 36 drugs
| Ozempic | 76 | $111,554 | $1,468 |
| Trulicity | 91 | $90,202 | $991 |
| Jardiance | 26 | $28,737 | $1,105 |
| Invokana | 34 | $28,564 | $840 |
| Humalog Kwikpen U-100 | 28 | $26,905 | $961 |
| Humalog Kwikpen U-200 | 11 | $23,448 | $2,132 |
| Farxiga | 31 | $20,584 | $664 |
| Tradjenta | 29 | $19,105 | $659 |
| Januvia | 17 | $16,850 | $991 |
| Lantus Solostar | 16 | $10,161 | $635 |
| Janumet Xr | 14 | $8,832 | $631 |
| Vascepa | 23 | $7,902 | $344 |
| Tresiba Flextouch U-100 | 15 | $6,737 | $449 |
| Lantus | 17 | $5,336 | $314 |
| Breo Ellipta | 12 | $4,612 | $384 |
| Toujeo Solostar | 13 | $4,024 | $310 |
| Repaglinide | 50 | $3,578 | $72 |
| Rosuvastatin | 63 | $3,090 | $49 |
| Valsartan | 24 | $1,836 | $77 |
| Acarbose | 15 | $1,768 | $118 |
| Ezetimibe | 16 | $1,540 | $96 |
| Glimepiride | 83 | $1,072 | $13 |
| Atorvastatin | 72 | $1,003 | $14 |
| Metformin Hcl Er | 77 | $883 | $11 |
| Synthroid | 11 | $784 | $71 |
| Irbesartan | 13 | $679 | $52 |
| Levothyroxine | 26 | $646 | $25 |
| Pioglitazone | 41 | $574 | $14 |
| Allopurinol | 26 | $502 | $19 |
| Losartan | 17 | $366 | $22 |
| Amlodipine Besylate | 53 | $354 | $7 |
| Glipizide | 31 | $346 | $11 |
| Lisinopril | 32 | $312 | $10 |
| Metformin | 26 | $274 | $11 |
| Gabapentin | 13 | $266 | $20 |
| Hydrochlorothiazide | 18 | $155 | $9 |
2019: 21 drugs
| Trulicity | 56 | $59,562 | $1,064 |
| Ozempic | 38 | $49,989 | $1,315 |
| Invokana | 14 | $9,590 | $685 |
| Jardiance | 12 | $8,244 | $687 |
| Farxiga | 11 | $7,252 | $659 |
| Tradjenta | 12 | $7,150 | $596 |
| Lantus Solostar | 13 | $4,358 | $335 |
| Valsartan | 33 | $1,663 | $50 |
| Rosuvastatin | 38 | $1,575 | $41 |
| Repaglinide | 31 | $1,507 | $49 |
| Ultra-Fine Nano Pen Needle | 17 | $1,269 | $75 |
| Glimepiride | 44 | $675 | $15 |
| Atorvastatin | 43 | $668 | $16 |
| Levothyroxine | 22 | $505 | $23 |
| Pioglitazone | 24 | $477 | $20 |
| Metformin Hcl Er | 55 | $424 | $8 |
| Irbesartan | 11 | $418 | $38 |
| Glipizide | 18 | $283 | $16 |
| Allopurinol | 14 | $233 | $17 |
| Lisinopril | 26 | $195 | $7 |
| Amlodipine Besylate | 21 | $81 | $4 |
Money from drug and device companies
$33 in 2025
| 2025 | 1 | 2 | None | $33 |
| 2022 | 1 | 1 | None | $12 |
| 2021 | 12 | 71 | None | $1,213 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Freestyle Libre 3 | $33 | 2 payments
|
See all 2 published payments
| Abbott Laboratories | Meals · 2025-07-08 | Freestyle Libre 3 | $16 |
| Abbott Laboratories | Meals · 2025-02-07 | Freestyle Libre 3 | $17 |
See earlier years (2022, 2021)
2022: $12
| Lilly USA | None | $12 | 1 payment
|
2021: $1,213
| Lilly USA | Trulicity | $356 | 16 payments
|
| Amgen | Evenity | $210 | 11 payments
|
| Novo Nordisk | Ozempic | $188 | 21 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $135 | 6 payments
|
| Insulet | Omnipod | $131 | 7 payments
|
| Merck Sharp & Dohme | Januvia | $57 | 3 payments
|
| Abbott Laboratories | Freestyle Libre | $29 | 2 payments
|
| Corcept Therapeutics | Korlym | $28 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $24 | 1 payment
|
| AbbVie | Synthroid | $24 | 1 payment
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $17 | 1 payment
|
| Xeris Pharmaceuticals | Gvoke Pfs | $13 | 1 payment
|
Professional record
- NPI
- 1982171278
- Licence
- CA 95009129
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2018-10-25
- NPI last updated
- 2021-09-28
- NPI record certified
- 2021-09-28
This is when the NPI record was last certified, not a medical board exam.